Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Fukushima M et al. | Prostaglandin A and J: antitumor and antiviral prostaglandins. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526507 |
Thierauch KH et al. | Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526554 |
Vigano' T et al. | Binding sites for histamine and sulfidopeptide leukotrienes in normal and hypersensitized human lung fragments. | 1990 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2144691 |
Ahmad AS et al. | Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice. | 2010 | Age (Dordr) | pmid:20640551 |
Kuiper J et al. | The role of prostaglandins in endotoxin stimulated glycogenolysis in the liver. | 1989 | Agents Actions | pmid:2653002 |
Church MK et al. | Mast cells, neuropeptides and inflammation. | 1989 | Agents Actions | pmid:2473641 |
van Overveld FJ | Mediator release from human lung mast cell subtypes in chronic bronchitis and emphysema. | 1989 | Agents Actions | pmid:2473645 |
Leung KB et al. | Some further properties of human pulmonary mast cells recovered by bronchoalveolar lavage and enzymic dispersion of lung tissue. | 1987 | Agents Actions | pmid:2440274 |
Kosaka Y et al. | Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung. | 1987 | Agents Actions | pmid:2442981 |
Jaffar ZH and Pearce FL | Some characteristics of the ATP-induced histamine release from and permeabilization of rat mast cells. | 1993 | Agents Actions | pmid:7511869 |
Ennis M et al. | Prostaglandin and histamine release from stimulated rat peritoneal mast cells. | 1984 | Agents Actions | pmid:6203356 |
MacIntyre DE et al. | Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators. | 1986 | Agents Actions Suppl. | pmid:3028106 |
Baumgarten CR et al. | Bradykinin and other inflammatory mediators in BAL-fluid from patients with active pulmonary inflammation. | 1992 | Agents Actions Suppl. | pmid:1462881 |
Matzkin ME et al. | Alterations in oxidative, inflammatory and apoptotic events in short-lived and long-lived mice testes. | 2016 | Aging (Albany NY) | pmid:26805572 |
Amano N et al. | The effect of pentobarbital and ether anesthesia on rat brain PGD2 content. | 1989 | Agressologie | pmid:2610292 |
Anton RF and Randall CL | Central nervous system prostaglandins and ethanol. | 1987 | Alcohol. Clin. Exp. Res. | pmid:3105343 |
Kojima K et al. | Effect of PPARgamma ligands on the viability of gastric epithelial cells. | 2002 | Aliment. Pharmacol. Ther. | pmid:11966526 |
Demoly P et al. | [Nose and sinus: anatomo-pathologic relations]. | 1998 | Allerg Immunol (Paris) | pmid:9631692 |
Oguma T et al. | Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma. | 2008 | Allergol Int | pmid:18946232 |
Higashi N et al. | Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites. | 2012 | Allergol Int | pmid:22627848 |